Yang H - Search Results

1

PIK3CA mutations and downstream effector p-mTOR expression: implication for prognostic factors and therapeutic targets in triple negative breast cancer.

Wang J, Zhu X, Xu X, Guo L, Shen G, Liu X, Chang C, Wang B, Yang H, Wang M. Wang J, et al. Among authors: yang h. Int J Clin Exp Pathol. 2017 Jul 1;10(7):7682-7691. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966614 Free PMC article.

2

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.

Zhu X, Ying J, Wang F, Wang J, Yang H. Zhu X, et al. Among authors: yang h. Breast Cancer Res Treat. 2014 Oct;147(3):551-5. doi: 10.1007/s10549-014-3136-y. Epub 2014 Sep 19. Breast Cancer Res Treat. 2014. PMID: 25234844

3

PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker.

Guo L, Li W, Zhu X, Ling Y, Qiu T, Dong L, Fang Y, Yang H, Ying J. Guo L, et al. Among authors: yang h. Springerplus. 2016 Jun 21;5(1):805. doi: 10.1186/s40064-016-2513-x. eCollection 2016. Springerplus. 2016. PMID: 27390646 Free PMC article.

4

[Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].

Li L, Bi XF, Xu X, Liu XY, Shen GH, Guo L, Yuan YL, Wang F, Wang MR, Yang HY. Li L, et al. Zhonghua Zhong Liu Za Zhi. 2010 Apr;32(4):273-7. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20510078 Chinese.

5

Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma.

Li L, Shi YH, Guo ZJ, Qiu T, Guo L, Yang HY, Zhang X, Zhao XM, Su Q. Li L, et al. World J Gastroenterol. 2010 May 28;16(20):2504-19. doi: 10.3748/wjg.v16.i20.2504. World J Gastroenterol. 2010. PMID: 20503450 Free PMC article.

6

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.

Shen Y, Han X, Wang J, Wang S, Yang H, Lu SH, Shi Y. Shen Y, et al. Among authors: yang h. Sci Rep. 2016 Apr 14;6:24310. doi: 10.1038/srep24310. Sci Rep. 2016. PMID: 27074743 Free PMC article.

7

Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.

Shen Y, Wang J, Han X, Yang H, Wang S, Lin D, Shi Y. Shen Y, et al. Among authors: yang h. PLoS One. 2013 Dec 10;8(12):e81628. doi: 10.1371/journal.pone.0081628. eCollection 2013. PLoS One. 2013. PMID: 24339949 Free PMC article.

8

Comparison of immunohistochemistry with fluorescence in situ hybridization in determining the human epidermal growth factor receptor 2 status of breast cancer specimens: a multicenter study of 3,149 Chinese patients.

Han X, Shi Y, Ma L, Lyu Z, Yang H, Yao J, Li J, Li B, Qin Y. Han X, et al. Among authors: yang h. Chin Med J (Engl). 2014;127(2):246-53. Chin Med J (Engl). 2014. PMID: 24438611

9

Relationship between serum HER2 extracellular domain levels, tissue HER2 expression, and clinico-pathological parameters in early stage breast cancer.

Ma L, Yang HY, Han XH, Li J, Wang F, Zhang CL, Yao JR, Shi YK. Ma L, et al. Chin Med J (Engl). 2012 Nov;125(22):4104-10. Chin Med J (Engl). 2012. PMID: 23158151

10

Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer.

Wang J, Yang H, Shen Y, Wang S, Lin D, Ma L, Han X, Shi Y. Wang J, et al. Among authors: yang h. Cancer Biomark. 2013;13(2):89-97. doi: 10.3233/CBM-130334. Cancer Biomark. 2013. PMID: 23838137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,176 results

Search Page

Filters